RPRX
Royalty Pharma plcNASDAQStock$62.20-0.14 (-0.23%)Mkt Cap 27.7BP/E 35.14Div Yield 1.49%Beta 0.41Vol 1.7MAvg Vol 3.2M
52W$36.41
$63.96
ETFs That Hold RPRX (Royalty Pharma plc)
1M
+6.20%
3M
+5.64%
6M
+25.18%
YTD
+59.93%
1Y
+68.70%
3Y
+126.99%
5Y
+64.99%
ETFs That Hold RPRX
Royalty Pharma plc is held by 207 ETFs. The largest position by market value is in VFLO (VictoryShares Free Cash Flow ETF).
| ETF | Fund Name | Weight |
|---|---|---|
| VFLO | VictoryShares Free Cash Flow ETF | 1.64% |
| IWR | iShares Russell Mid-Cap ETF | 0.18% |
| VYM | Vanguard High Dividend Yield ETF | 0.10% |
| CGDG | Capital Group Dividend Growers ETF | 1.22% |
| IHE | iShares U.S. Pharmaceuticals ETF | 4.46% |
| IWD | iShares Russell 1000 Value ETF | 0.07% |
| MTUM | iShares MSCI USA Momentum Factor ETF | 0.20% |
| IWS | iShares Russell Mid-Cap Value ETF | 0.24% |
| GSLC | Goldman Sachs ActiveBeta U.S. Large Cap Equity ETF | 0.24% |
| VETS | Pacer Military Times Best Employers ETF | 0.08% |
| DGRO | iShares Core Dividend Growth ETF | 0.07% |
| GFLW | Victory Portfolios II - Victoryshares Free Cash Flow Growth ETF | 2.49% |
| FNDA | Schwab Fundamental U.S. Small Company Index ETF | 0.32% |
| SCHX | Schwab U.S. Large-Cap ETF | 0.04% |
| VLUE | iShares MSCI USA Value Factor ETF | 0.27% |
| JQUA | JPMorgan U.S. Quality Factor ETF | 0.24% |
| PBE | Invesco Biotechnology & Genome ETF | 4.80% |
| ESGU | iShares ESG Aware MSCI USA ETF | 0.11% |
| INFL | Horizon Kinetics Inflation Beneficiaries ETF | 1.29% |
| NULV | Nuveen ESG Large-Cap Value | 0.72% |
Excludes leveraged and inverse ETFs.
Page 1 of 11Next
Frequently Asked Questions
How many ETFs hold RPRX?
Royalty Pharma plc (RPRX) is held by 207 ETFs (excluding leveraged and inverse funds). The largest position by market value is in VFLO (VictoryShares Free Cash Flow ETF).
What is the largest ETF that holds RPRX?
By fund size, VFLO (VictoryShares Free Cash Flow ETF) with $11.84B in AUM holds 1.64% of its portfolio in RPRX, representing $194.8M in market value.
What percentage of PBE is RPRX?
RPRX makes up 4.80% of PBE (Invesco Biotechnology & Genome ETF), making it one of the largest positions in that fund.
Is RPRX in the S&P 500?
RPRX is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.